Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU ...

Galderma (SIX: GALD), today announced that regulatory authorities in the EU, the U.S., and Canada have approved a new state-of-the-art syringe for use with its NASHA® lidocaine range of Restylane ...
Pharmabiz

EU, US and Canada approves Galderma’s new state-of-the-art Restylane syringe

EU, US and Canada approves Galderma’s new state-of-the-art Restylane syringe: Zug, Switzerland Thursday, February 26, 2026, 13:00 Hrs [IST] Galderma, the pure-play dermatology c ...